Drugs / LY3025876
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01870297 | Jun 2013 → Dec 2014 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 1 | NCT01528124 | Feb → May 2012 | — | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY3025876 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01528124 ↗ |
| Route | Subcutaneous | “Given as a subcutaneous injection” NCT01528124 ↗ |